These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 8393371)

  • 1. Mutations of p53 and human papillomavirus infection in cervical carcinoma.
    Paquette RL; Lee YY; Wilczynski SP; Karmakar A; Kizaki M; Miller CW; Koeffler HP
    Cancer; 1993 Aug; 72(4):1272-80. PubMed ID: 8393371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
    Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix.
    Kessis TD; Slebos RJ; Han SM; Shah K; Bosch XF; Muñoz N; Hedrick L; Cho KR
    Am J Pathol; 1993 Nov; 143(5):1398-405. PubMed ID: 8238255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
    Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
    Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low frequency of p53 mutations in cervical carcinomas among Brazilian women.
    Pinheiro NA; Villa LL
    Braz J Med Biol Res; 2001 Jun; 34(6):727-33. PubMed ID: 11378660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 mutations in HPV-negative cervical carcinoma.
    Park DJ; Wilczynski SP; Paquette RL; Miller CW; Koeffler HP
    Oncogene; 1994 Jan; 9(1):205-10. PubMed ID: 8302581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines.
    Iwasaka T; Oh-uchida M; Matsuo N; Yokoyama M; Fukuda K; Hara K; Fukuyama K; Hori K; Sugimori H
    Gynecol Oncol; 1993 Jan; 48(1):104-9. PubMed ID: 8380785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours.
    Crook T; Wrede D; Tidy JA; Mason WP; Evans DJ; Vousden KH
    Lancet; 1992 May; 339(8801):1070-3. PubMed ID: 1349102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
    Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G
    Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of p53 inactivation in human cervical cell carcinoma development.
    Miwa K; Miyamoto S; Kato H; Imamura T; Nishida M; Yoshikawa Y; Nagata Y; Wake N
    Br J Cancer; 1995 Feb; 71(2):219-26. PubMed ID: 7841033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection.
    Lo KW; Mok CH; Chung G; Huang DP; Wong F; Chan M; Lee JC; Tsao SW
    Anticancer Res; 1992; 12(6B):1989-94. PubMed ID: 1363512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53, retinoblastoma, and human papillomavirus in squamous cell carcinoma and adjacent normal mucosa of the upper aerodigestive tract.
    Lee NK; Ye YW; Chen J; Li X; Waber PG; Nisen PD
    Arch Otolaryngol Head Neck Surg; 1993 Oct; 119(10):1125-31. PubMed ID: 8398064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 alterations and HPV infections are common in oral SCC: p53 gene mutations correlate with the absence of HPV 16-E6 DNA.
    Penhallow J; Steingrimsdottir H; Elamin F; Warnakulasuriya S; Farzaneh F; Johnson N; Tavassoli M
    Int J Oncol; 1998 Jan; 12(1):59-68. PubMed ID: 9454887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Human papillomavirus, human cytomegalovirus and p53 gene in cervical carcinoma].
    Zhao W; Si J; Li K
    Zhonghua Fu Chan Ke Za Zhi; 1995 Nov; 30(11):654-7. PubMed ID: 8745488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with stage IIIB cervical carcinoma treated with radiation therapy alone.
    Ishikawa H; Mitsuhashi N; Sakurai H; Maebayashi K; Niibe H
    Cancer; 2001 Jan; 91(1):80-9. PubMed ID: 11148563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 status and human papillomavirus infection in Thai women with cervical carcinoma.
    Limpaiboon T; Pooart J; Bhattarakosol P; Niruthisard S; Chantratita W; Lulitanond V
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):66-71. PubMed ID: 11023067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus.
    Jiko K; Tsuda H; Sato S; Hirohashi S
    Int J Cancer; 1994 Dec; 59(5):601-6. PubMed ID: 7960232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
    Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
    Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis.
    Chang F; Syrjänen S; Tervahauta A; Kurvinen K; Wang L; Syrjänen K
    Br J Cancer; 1994 Aug; 70(2):346-51. PubMed ID: 8054284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.